Persistent activation of STAT3 also contributes to tumorigenesis by upregulating the transcription of genes that control cancer cell survival (e.g., cyclins and c-MYC [53,54]), resistance to apoptosis (e.g., BCL2, MCL1 [55]), and cell cycle activation [56]. This evidence concerns the gene BCL2 and cancer.